Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Sivelestat
The First People's Hospital of Lianyungang
Aortic Dissection
1 trial -
Sivelestat sodium
The First People's Hospital of Lianyungang
Aortic Dissection
1 trial -
Siwu Tang
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Brain Hypoperfusion Syndrome
1 trial -
Snap
The First People's Hospital of Lianyungang
Arrhythmia
1 trial -
Sniffing emotional tears
Hospital Authority, Hong Kong
Obesity
1 trial -
Sodium Bicarbonate Ringer's Solution
The First People's Hospital of Lianyungang
Hyperlactacidemia
1 trial -
Solifenacin Succinate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Overactive Bladder
1 trial -
Specific Carbohydrate Diet
NORTHWEST BIOTHERAPEUTICS INC
Clostridium Difficile Infection
1 trial -
Sperm test
The First People's Hospital of Lianyungang
Covid19
1 trial -
Spleen Invigorating and Weight Reducing Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Traditional Chinese Medicine Treatment
1 trial -
Split dose of 4L PEG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Health Behavior
1 trial -
Standard Dose Spirulina Platensis
Hospital Authority, Hong Kong
HBV Carrier
1 trial -
Standard clinical treatment
The First People's Hospital of Lianyungang
Acute Pancreatitis
1 trial -
Stapokibart
The First People's Hospital of Lianyungang
Primary Cutaneous Amyloidosis
1 trial -
Statin
Hospital Authority, Hong Kong
HCC
1 trial -
Stereotactic body radiotherapy (SBRT)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HSCT
1 trial -
Steroid and Proton Pump Inhibitor Therapy
Takeda
Suspected Eosinophilic Esophagitis
1 trial -
Study Product A (High-dose 2X)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hyperuricemia
1 trial -
Suanzaoren Decoction and Huanglian Wendan Decoction
The First People's Hospital of Lianyungang
Traditional Chinese Medicine
1 trial -
Subconjunctival dexamethasone and general anesthesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cataract
1 trial -
Sucrose IronοΌsubcutaneous recombinant human erythropoietinοΌintravenous vitamin C
The First People's Hospital of Lianyungang
Anemia
1 trial -
Sufentanil
The First People's Hospital of Lianyungang
Anesthesia
1 trial -
Sulfentanyl
The First People's Hospital of Lianyungang
Postoperative Nausea and Vomiting
1 trial -
Surgery combined with Target-reduction intensity-modulated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources